Did COVID outbreak influence our management of skin tumors?

dc.contributor.authorYeğin, Mehmet Emre
dc.contributor.authorGür, Ersin
dc.contributor.authorYeğin, Ecem Esma
dc.contributor.authorTiftikçioğlu, Yigit Ozer
dc.date.accessioned2023-01-12T20:38:06Z
dc.date.available2023-01-12T20:38:06Z
dc.date.issued2022
dc.departmentN/A/Departmenten_US
dc.description.abstractAim: COVID pandemic forced new medical protocols. COVID precautions also changed surgical algorithms causing a change in medical costs. This study aims to clarify COVID-era medical costs and underlying reasons for patients with Head & Neck (H&N) area skin tumors. Materials and Methods: Patients which were operated for H&N tumors in our clinic before and during the COVID outbreak were retrospectively analyzed per sex, age, etiology, PPE usage, treatments, and total costs. Statistical analysis was done for any significant changes. Results: A total of 127 patients of which 70 were operated before (G1) and 57 were operated after (G2) the COVID out-break for H&N tumors were evaluated. Mean ages were 69,94 years for G1 and 65,56 for G2. 28 BCC and 42 SCC patients were in G1 and 11 BCC and 46 SCC patients were in G2. In G1, 69 wide excisions, 44 skin graft, 17 skin flaps, 6 lymph node dissections (LNDs) were done. In G2, 56 wide excisions, 30 skin grafts, 9 skin flaps, 6 LNDs, 5 free flaps were done. G1 patients were hospitalized for a median of 2 days, while G2 patients were hospitalized for a median of 3 days. Median costs were $261,42 in G1 and $624.84 in G2. Statistical analysis with Mann-Whitney-U and Chi-Square tests revealed significant difference only between the costs. When disposable PPE was excluded, the median cost of G2 became $539.84 (G3). Statistical difference between G1 and G3 was found to be insignificant. Conclusion: COVID changed the etiology of our patient groups. However, our treatment protocols, hospitalization lengths, and costs remain the same. Our patient profile and treatment protocols remain similar, but COVID precautions add an extra burden.en_US
dc.identifier.endpage57en_US
dc.identifier.issn1016-9113
dc.identifier.issn2147-6500
dc.identifier.issue1en_US
dc.identifier.startpage53en_US
dc.identifier.trdizinid1115470en_US
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/1115470
dc.identifier.urihttps://hdl.handle.net/11454/81839
dc.identifier.volume61en_US
dc.indekslendigikaynakTR-Dizinen_US
dc.language.isoenen_US
dc.relation.ispartofEge Tıp Dergisien_US
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.titleDid COVID outbreak influence our management of skin tumors?en_US
dc.typeArticleen_US

Dosyalar